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Abstract

It is estimated that over 90% of hospitalized patients require IV access during their
hospitalization. Peripheral IVs (PIVs), while less risky than central lines, are not without risk to
the patients. Intravenous (IV) infiltration in pediatric patients is a very common complication
associated with IV access, accounting for about 67% of IV catheter removals; a less common
complication, but much more serious complication of a PIV can be a blood stream infection
(BSI) which can account for up to 35% of BSIs seen in patients. BSIs are associated with
increased length of stay, increased morbidity and can result in patient death. In addition, BSIs
are estimated to cost approximately $30,000 per infection to treat. IV infiltrates result in pain for
the patients, another painful procedure and in 11%-25% of severe cases can result in plastic
surgery and long-term complications. The goal of this project was to evaluate if a Peripheral IV
Bundle can decrease complications associated with PIVs; specifically, efforts were focused on
preventing IV infiltrates and BSIs, as well as decreasing the number of IV starts a patient
experiences during a hospitalization.
Results: Compliance with the new PIV bundle averaged 51% over the 5 month time frame,
however did improve with each month. IV infiltrates rates decreased from the preimplementation phase to the post-implementation from 19.16/1000 patient days to 15.87/1000
patient days (P=0.556). PIV duration increased from 71 hours pre implementation to 99 hours
post implementation.
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Background/Significance

It is estimated that over 90% of hospitalized patients require IV access during their
hospitalization (Taylor, 2014). Peripheral IVs (PIVs), while less risky than central lines, are not
without risk to the patients especially pediatric patients. Intravenous (IV) infiltration in pediatric
patients is a very common complication associated with IV access, accounting for up to 78% of
IV catheter removals (Major & Huey, 2016); a less common complication, but much more
serious complication of a PIV can be a blood stream infection (BSI). PIVs can account for up to
35% of BSIs seen in patients (Rhodes, et al, 2016). BSIs are associated with increased length of
stay, increased morbidity and can result in patient death. In addition, BSIs are estimated to cost
approximately $30,000 per infection to treat (Raphael, Hazekamp, Samnaliev, & Ozonoff, 2018).
IV infiltrates result in pain for the patients, another painful procedure and in 11%-25% of severe
cases can result in plastic surgery and long-term complications (Chenoweth, Guo, & Chan,
2018).
The CDC found that PIV associated BSIs can be as high as 0.5/1000 line days compared
to 1.14/1000 line days for CLABSI (Devries, Valentine, & Mancos, 2016). It is estimated that
about 50% of patients who have a central line in place also have a PIV in place indicating that
some CLABSIs could be caused by poor PIV site care (Devries, et al, 2016). Two Neonatal
studies found that 30-37 hours is the average length of time a PIV can be in place before
complications arise causing the catheter to be removed (Chenoweth, et al, 2018). Because of
complications associated with PIVs, it is estimated that approximately 95% of PIVs are removed
before therapy is complete, causing the patient to receive multiple PIV starts during the hospital
stay (Chenoweth, et al, 2018).
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Norton Children’s Hospital’s (NCH) Pediatric ICU (PICU) has dedicated time and
attention to implementing evidence-based practices to help reduce patient harm and hospital
acquired conditions (HACs). However, we continue to fall short in our goal of zero harm events
for our patients; PIV site care has been identified as an area where we can improve. In 2018, we
had 229 PIV infiltrates in the PICU alone, with almost 50% of patients having two or more
infiltrates. In the last quarter of 2018, we had five patients with severe infiltrates requiring
plastic surgeon consultation; three of them resulted in surgical intervention.
In addition to IV infiltrates, we have not been able to reach zero HAC events related to
(CLABSI). While we were able to decrease our CLABSI rates from 11 in 2017 to 5 in 2018, we
continue to see variation in our CLABSI rate from year to year. Also in 2018, we had eight
patients in our care who had BSIs not associated with a Central Line. Of our five CLABSI in
2018, four of those patients had PIVs in place in addition to their central line.
To further explore these issues data were collected from January to April 2019 utilizing
an infiltrate tracking form that the nurses or IV team completed with each infiltrate. This form
asked for the size of catheter, age of patient, drug infusing, rate of infusion, stage of infiltrate,
treatment given to the patient, and frequency of assessments. I relied on the nurses to complete
this form in real time as documentation in EPIC does not reflect all of this information and often
times information such as IV infiltrate staging was missing within EPIC documentation. After
compiling data on 58 IV infiltrates during that time I found the following: 67% of infiltrates
were associated with 24 gauge IV catheters, 50% of infiltrates occurred in patients <1 year of
age, and lipids and IVFs were the most common drug infusing during infiltration, occurring in
24% and 27% of the infiltrates respectively. The data also showed that nurses had done an IV
assessment within the previous hour on 82% of infiltrates and that Hyaluronidase was given as a
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treatment in 37% of cases. Hyaluronidase is a drug injected into the tissue surrounding the
infiltrate to neutralize the drug that infiltrated into the tissue. Most infiltrates were mild in
severity with 27% being moderate in severity and only one documented case of a severe
infiltrate. As a result of these findings, it was evident that we had room to improve the care of
PIVs in the ICU and the outcomes of the patients.
The literature suggests that no single intervention will eliminate BSIs associated with
PIVs, IV infiltrates, or even decrease painful procedures for patients. The interventions in place
prior to the bundle implementation included using CHG to prepare the skin prior to an IV
insertion, utilizing a securement device, utilizing alcohol impregnated caps on IVs, changing IV
tubing every 96-120 hours and applying a transparent dressing that is changed when soiled or unocclusive. Wearing sterile gloves was only done when drawing a blood culture and utilization of
an IV start kit was optional. There was no method to educate the families on PIV site care and
engaging them to speak up if they have concerns about the site. While Extended Peripheral IVs
(EPIVs) had been available for many years, it was rarely done for ICU patients because the IV
team was being consulted after the patient has already lost multiple IVs and had very little access
remaining. Engaging the IV team sooner based upon the patient’s predicted therapy was hoped
to increase the number of successfully placed EPIVs in our patients.
Purpose Statement
The purpose of this project was to develop a PIV bundle that would decrease PIV
infiltrations, IV attempts, and painful procedures patients experience during their stay and
decrease the number of hospital acquired bacteremias patients acquire while in our care.
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Literature Review

The literature supports several different interventions to improve PIV site care in order to
decrease PIV complications. Nursing education was cited by Taylor (2015) as potentially having
an impact on PIV site care and reduction of IV infiltrations, but this was the only study that
utilized nursing education alone. In a study by Rhodes et al. (2016), the authors campaigned to
increase awareness of PIV site complications, nursing education, improved documentation, alerts
for PIVs inserted outside of the hospital setting to initiate removal within 24 hours, and a PIV
insertion kit. Using this protocol, they were able to decrease their PIV associated
Staphylococcus aureus BSIs by 50%. Major and Huey (2016) found that by combining staff
education, IV securement, and family involvement through Get Well Network, IV infiltrates
decreased from a rate of 13.5/1000 PIV days to 7.1 post implementation. A study by Rojas &
Benish (2018) found that family education and involvement resulted in a 14% increase in the
Touch/Look/Compare (TLC) assessment of IVs, as well as a 23% reduction in extravasation
rates. This was accomplished by educating the families on PIV site assessments, as well as
utilizing an interactive care network where questions regarding the IV site were sent to the
family. If there was a family concern, a prompt was sent to the nurse leader to assess the IV site.
Park, Jeong, Kim, Park and Jeong (2016) also found that they were able to significantly decrease
IV infiltration rates when they educated the parents and had them assist in site observation.
Devries et al (2016) found that by developing a standardized IV start kit they were able to
decrease overall BSIs by 37% and BSIs associated with PIVs by 19%. These kits consisted of
chlorhexidine gluconate (CHG) skin prep; sterile gloves; IV catheters with integrated extension
sets; CHG impregnated dressing, securement dressing, and alcohol caps. In the study by
DeVries et al (2016), one hospital was able to decrease BSIs associated with PIVs by 66% over
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15 months with the implementation of a PIV bundle. This bundle consisted of IV catheters with
integrated extension tubing, a neutral needle free cap, alcohol caps, sterile gloves, transparent
dressings, securement device, and CHG disk. Sterile gloves are indicated by the Centers for
Disease Control (CDC) during PIV insertions where the site may be palpated after the CHG prep
(CDC.gov).
The use of extended dwell peripheral IV (EPIV) was found in a study by Chenoweth and
Chan, (2018) to decrease IV infiltrations, as well as the number of IV starts a patient
experiences. These catheters are typically 6 or 8 cm. in length, making them longer than a PIV,
but shorter than a peripherally inserted central catheter (PICC). These catheters are intended to
last up to 29 days and could be considered for IV therapy requiring an extended period; these
extended care catheters cannot be used with any type of vein irritating drugs. In this study, they
inserted EPIVs into 432 neonates to evaluate if there were complications associated with EPIVs
as well as their longevity. They found that average dwell time for an EPIV was 8.7 days
compared to 30 hours for a PIV and that over 50% of EPIVs lasted through the duration of their
therapy, compared to only about 5% of PIVs. There were no life-threatening complications
associated with the EPIVs in this study (Chenoweth & Chan, 2018). It was concluded that
EPIVs are a feasible option in the neonatal population to help decrease complications for PIVs,
as well as decrease the number of painful procedures the patient experiences.
It is evident from the literature that there are many different interventions that could have
an impact on IV infiltrate rates, infection rates, and the number of IV starts a patient experiences.
After reviewing the literature, I implemented a combination of interventions including an attempt
to increase the use of EPIV catheters which have been shown to have an impact on all three
outcomes of concern. In addition, NCH did not have a formalized bundle focused on insertion
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and maintenance of PIVs, so much of my work focused on developing a bundle for bedside
nurses to reference incorporating many of the interventions found in the literature.
Evidence Based Practice Model
I used the Iowa Model of Evidence Based Practice to Promote Quality Care (Doddy,
2011) to guide me as I looked to develop a PIV bundle for the Pediatric Intensive Care Unit
(PICU). This model was developed at the University of Iowa in 1990 as a guide for nurses to
implement evidence-based practice to impact patient outcomes (Doddy, 2011). The model
utilizes eight steps; 1) Identification of problem, 2) determination of priority within organization,
3) team development, 4) gathering and analyzing research, 5) critiquing and synthesizing the
research, 6) determining if evidence supports a practice change; if not then the work is complete,
if there is continue to step 7) implement pilot program and finally step 8) evaluate the pilot
program to determine if system-wide implementation is warranted.
Applying the model, I found there was both a problem focused trigger and knowledge
focused trigger for the organization to make this a priority. Our risk management team had
noticed an increase in the severity and frequency of patient harm events related to PIV infiltrates.
Additionally, we are part of the “Solutions for Patient Safety Collaborative”, where there is ongoing work related to peripheral IV infiltration and extravasation (PIVIE) prevention however
our hospital had yet to join this team.
I first began my teambuilding within the PICU and then the team broadened to include
others from outside of the PICU to look at a hospital wide approach. My project was focused on
work within the PICU, so my team was comprised of our two clinical assistant nurse managers
who collect quality data and provide bedside support to our nurses, our medical director, the IV
team for the hospital, and other staff members who had an interest in PIVIE prevention. After
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doing my literature review and synthesizing my findings, I shared what I found with our Unit
Based Council team to see what was reasonable to implement within the PICU. Because many
of the studies looked at different bundle components, it was hard to determine which bundle
elements had the greatest impact on the outcomes we were targeting. Having already collected
baseline data in early 2019, we did not pilot the change, but instead involved the key
stakeholders who were bedside nurses and the IV team to ensure the bundle components we
included could be implemented within the constraints of our existing system.
Methods and Procedures
Sample and Setting
The sample for the project were all patients who were admitted to the PICU during
January 2020-May 2020. The inclusion criterion was the need for a PIV, which includes nearly
all of our patient population. The setting was the PICU, a 26 bed pediatric ICU located within
Norton Children’s Hospital. Norton Children’s Hospital (NCH) is Kentucky’s only full-service,
free-standing, tertiary care facility dedicated exclusively to children. NCH is a 265 bed, nonprofit organization which is part of a larger Norton Healthcare (NHC) system and is affiliated
with the University of Louisville’s School of Medicine.
Intervention
Table 1 depicts the PIV bundle elements, both interventions that were already in place as
well as the newly implemented interventions. The newly implemented bundled elements
included making sterile gloves or reapplying CHG to the insertion site after palpation standard of
care, as well as utilization of an IV start kit with each insertion to ensure the puncture site is not
contaminated during the procedure. The other two new elements included utilizing a vascular
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access algorithm upon admission to determine if the IV team should be consulted for an EPIV
and educating and involving families in the assessment of PIVs. (Appendix A)

Table 1
Peripheral IV Bundle
*Use Non-Emergent Vascular Access Algorithm to assess if Patient is a candidate for Extended Dwell PIV, PICC or
CVL upon admission or as condition changes.
*Hand Hygiene prior to starting procedure
*CHG to prep skin for PIV insertion
*Sterile gloves or re-prep for insertions where site is palpated after skin prep.
*IV start Kit for all IV starts
*Stat-lock securement device on all PIVs unless contraindicated by patient size
*Occlusive dressing in place-changed only when soiled or un-occlusive.
*Touch Look Compare (TLC) assessment performed every hour when IV fluids infusing
(Site must be visible to accurately assess)
TLC assessment with saline flush every 6 hours for saline lock.
*Alcohol caps used for all caps/tubing on PIVs
*IV Tubing for fluids are dated/timed and changed every 96-120 hours
*Educate/engage families on PIV infiltrate signs/symptoms and ask them to partner with nursing on IV assessments

Given that the IV team had a limited number of staff and that EPIVs could only be placed
by this team, we wanted to ensure that this was a feasible option. The identified barrier to
inserting EPIVs was the time lost waiting on supplies to arrive at the bedside; to combat this,
EPIVs were stocked on the unit and then replenished after the EPIV was inserted ensuring stock
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on the unit, but decreasing the time the IV team took to place the EPIV catheter. As the
physicians did not feel it necessary to have a physician order to place an EPIV, the nurses could
utilize clinical judgement along with the vascular access algorithm (see Appendix A) to request
an EPIV.
Families were asked to assist with the Touch, Look, Compare (TLC) assessments and to
alert a member of the health care team if they had concerns (see Appendix B), but this element
did not replace the nursing assessments. The TLC assessment is performed hourly by nursing
when a patient has running IVFs. The assessment consists of touching the site/extremity of the
PIV to ensure the tissue is soft, warm and pain free, looking at the site to make sure the site is not
reddened and comparing one extremity to the other to assess for swelling.
We educated the staff on the changes to the bundle elements in several different ways
during the month of December to help ensure that the bundle elements were understood. The
PICU unit-based practice council was first shown the final bundle, along with education tools to
help them to answer questions and support staff on the unit. The unit holds weekly education
sessions that are offered before each shift where we educated all staff on the new bundle
elements. Information was also placed in the monthly Power Point staff meeting that is sent to
all PICU staff. As well, the IV team leader shared the bundle with her team during their monthly
staff meetings. Finally, posters were placed throughout the unit as a reference to the new bundle
and informal education huddles were held in patient care areas the two weeks prior to bundle
implementation.
It was also noted during the initial data collection period that many of the PIVs that were
removed due to infiltration did not have a stage documented in the electronic medical record
(EMR). The barrier identified was the EPIC documentation screens. The nurse was required to
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go to two different locations in EPIC to document when an IV was removed for infiltration if
they were going to include the staging. This resulted in many of the IVs being documented as
removed due to infiltration, but no staging was documented because the nurse had to remember
to go back and document the staging in a different area. Our EPIC analyst was consulted to help
improve our PIV discontinuation documentation. We were able to have the staging
documentation moved to the same location in EPIC where the nurse documented the IV being
removed and the reason in an effort to improve accurate documentation of removed PIVs.
Measures and Data Collection
The new bundle compliance was monitored by the PICU clinical support assistant nurse
managers (CS ANM). Monitoring was done via the Kamishibai card (K card) method allowing
for staff involvement and real time feedback about areas of bundle non-compliance (Shea, Smith,
Knobloch, & Safdar, 2018). This method of data collection utilizes the posting of a K card for
each audit with the green (compliant observation) or red (“defects” founds) side showing. A
“newspaper” is also posted in the unit, showing what areas of the bundle were non-compliant
with each observation along with any reason for non-compliance that was noted in talking with
the staff. The K cards change daily based upon that days’ audits and the newspaper remains up
for a month. (See Appendix C).
EPIC analysts built a PIV infiltration report that would pull each month showing the
patients who had an IV infiltrate during their stay in the PICU. This report was used to collect
PIV data during both the pre and post implementation phases of the project. Utilizing these
reports patients were identified who had acquired an IV infiltrate while in the PICU and further
data was collected by accessing each patient’s record. Data collected on each patient with an
infiltrate included: hospital length of stay (LOS), total number of infiltrates acquired during the
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entire hospital stay, the number of IV attempts documented during the hospital stay, the duration
of each PIV, the removal reason of each IV catheter, the size of each catheter, and the infiltrate
stage if appropriate. Statistical analysis utilized the Mann-Whitney U test since there were 2
independent groups being compared with ordinal data for each group.

Results
Bundle Implementation
Pre-intervention data from July 2019-November 2019 was pulled and compared to postintervention data from January 2020-May 2020. There were 131 K card Bundle audits done over
the 5-month time span post intervention and compliance increased each month from 20% in the
first month up to 61% at the end of month five with an overall bundle compliance over the five
months of 51%. The most common “defect” in the bundle was performance of TLC assessments
appropriately. The CS ANMs did not just ask nurses to describe the TLC assessment, but
instead, went into rooms with the staff and watched them perform an assessment. The second
most common “defect”, occurring 28 times, was staff not utilizing the vascular access algorithm
to determine the most appropriate access for their patient. These data were not surprising given
that only four EPIVs were attempted during the post implementation phase of the PIVIE bundle.
Infiltration Rates
Table 2 shows the catheter size, sites, removal reason, infiltrate staging for both the pre
and post-intervention period. All patients who acquired a PIV infiltrate while in the PICU during
the pre and post time periods were included in the data analysis, for a total of 86 patients. In
2019, there were a total of 62 patients who acquired a PIV infiltrate while in the PICU with a
total of 351 IVs inserted, for an average of 5.61 IVs/patient. In comparison, in 2020 there were
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24 patients who acquired an IV infiltrate with a total of 108 IVs inserted, for an average of 4.69
IVs/patient.
Table 3
PIV Characteristics
Size
24 Gauge
22 Gauge
Other

n
229
85
39

Pre
64.9%
24.1%
11.0%

n
45
56
7

Post
41.7%
51.9%
6.5%

Sites
Hand
AC
Scalp
Foot
Wrist
Saphenous/Ankle
Other

123
50
21
71
26
32
30

34.8%
14.2%
5.9%
20.1%
7.4%
9.1%
8.5%

35
14
3
20
5
7
24

32.4%
13.0%
2.8%
18.5%
4.6%
6.5%
22.2%

Reason PIV Removed
Infiltrate
Occluded
Leaking
Patient Removed
Not Patent
Patient Discharged
Misc
Not Documented

149
36
45
24
29
13
45
12

42.2%
10.2%
12.7%
6.8%
8.2%
3.7%
12.7%
3.4%

41
10
11
4
4
7
19
12

38.0%
9.3%
10.2%
3.7%
3.7%
6.5%
17.6%
11.1%

Infiltrate Stage
Stage 1
Stage 2
Stage 3
Stage 4
Stage 5
Not Documented

49
34
10
3
0
53

32.9%
22.8%
6.7%
2.0%
0.0%
35.6%

18
8
3
1
0
11

43.9%
19.5%
7.3%
2.4%
0.0%
26.8%

Average LOS
Total Attempts

20.03
316

26.13
125
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Figure 1 shows the IV infiltrate rate/1000 patient days during the two time periods. The
number of IV infiltrates/1000 patient days dropped after implementation of the PIVIE bundle
from 19.16 to 15.87. However, this decrease was not statistically significant utilizing an
independent-sample T-Test (T=0.616, P=0.556). While clinically significant, the number of
moderate IV infiltrates/1000 patient days decreased post intervention, was not statistically
significant (U=4, P=0.095). There were no severe IV infiltrates in the pre-intervention period as
compared to 2.05/1000 patient days in the post intervention period resulting in no statistical
significance (U=15, P=0.690).
Figure 1

Infiltrate Rate
35
30
25
20
15
10
5
0

Overall Rate/1000 Patient Days

Moderate/1000 patient days

Severe/1000 patient days.

Table 2 compares data related to infiltrates, number of PIVs, and number of IV attempts
from the pre and post intervention periods. Analyses were performed comparing the
infiltrates/LOS, total number of IVs/LOS and the number of attempts/IV utilizing the Mann
Whitney U test. Given that LOS varied for each patient depending on their diagnosis,
comparison was made for infiltrates/LOS in addition to comparing the standard reporting method
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of infiltrates/1000 patient days. Infiltrates/LOS increased in the post implementation period
from 0.193 to 0.438 on average (U=715, P=0.334), however, this was not statistically significant.

Table 2
Summary of PIV Data
Post-Intervention Significance
23
108

Total Number of Patients
Total IV Catheters

Pre-Intervention
62
353

Infiltrates/1000 Patient Days
Infiltrates/LOS
PIVS/LOS
Attempts/IV

19.16
0.193
0.418
1.45

15.58
0.438
0.923
1.35

P=0.556
P=0.334
P=0.772
P=0.401

Average Catheter Duration
Average Attempts/Patient/Hospital
Stay

71

99

P=0.926

7.24

4.72

P=0.035

IV Attempts
IVs/LOS also increased in the post implementation period from 0.418 to 0.92 on average
(U=715, P=0.772), but not significantly. However, attempts/IV decreased from 1.45 to 1.35
(U=602, P=0.401). No significant difference was found during the pre and post intervention
periods. The average number of IV attempts per patient was a dramatic decrease from the pre
and post intervention periods, 7.42 to 4.72, and was a statistically significant decrease (U=475,
P=0.035). However, many of the PIVs were missing attempt numbers, so these data may not be
a true reflection of attempts. The PIV catheter duration increased from an average of 71 hours
up to 99 hours from the pre to post intervention periods, however this was not a statistically
significant change (U=2924, P=0.926).
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EPIV Insertions
In 2019, there were 6 EPIV attempts with 5 successful EPIVs placed. These EPIVs
ranged in duration from 4-10 days and two of the four were removed because of complications;
one infiltrated and one had drainage. In comparison, there were only 4 attempts made in the
post-intervention period with 3 successful placements. Catheter duration ranged from 4-12 days
in this period with none of them being removed due to complication.
BSI rates
There were no patients in either the pre or post-intervention period who acquired a BSI
with only a PIV in place. The number of patients who acquired a CLABSI with both a central
line and PIV in place was also unexpectedly low during the project period. The ICU had zero
CLABSIs from July-November 2019, which was different from the first 6 months of the year.
During the post intervention period, the PICU had one patient (in January) who acquired a
CLABSI and had peripheral IVs in place as well. This CLABSI was attributed to a mucosal
barrier injury which is often seen in our oncology patient population and not related to care of
the central line or peripheral IV. During the project period, many discussions were taking place
on the unit about reducing all hospital acquired conditions and the unit had focused more energy
around hand hygiene compliance and increasing awareness of the 5 moments of hand hygiene
which may have impacted these results in a positive way.
Discussion
We have seen that care bundles have improved patient outcomes in many other areas of
care including; Ventilator Associated Pneumonia (VAP), Catheter Associated Urinary Tract
Infections (CAUTI), and CLABSIs. Therefore, a care bundle related to PIV care should only
improve outcomes for patients who have PIVs in place. Development of the proper bundle
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components is key. However, this bundle would need to be studied over a longer period of time
to know if we have captured the proper components.
As with many new changes in care, auditing compliance and continued feedback is one
of the most proven methods to improve compliance with the change. The K card process allows
for real time feedback to the staff as to which specific areas are not compliant with the bundle,
helping to improve compliance over time. Bundle compliance will likely continue to increase
each month, with a goal of 90% or higher. Outcomes have shown the greatest improvement once
90% compliance is achieved (Shea, Smith, Knobloch, & Safdar, 2018). Improving TLC
assessment techniques and utilization of the Vascular Access algorithm should result in higher
compliance and in turn decrease IV infiltrates as well as IV starts.
PIV infiltrates are a common occurrence in the pediatric population, often resulting in
more IV starts and possible long-term complications depending on the severity of the infiltrates.
There are many barriers to catching IV infiltrates in the early stages such as nursing workload,
IV site visibility because of securement methods and nurses’ inability to accurately identify an
infiltrate. Overall, the implementation of the PIVIE bundle in the PICU did not result in
statistically significant changes in IV infiltrate rates or the number of IV attempts. While we did
see an overall decrease in the number of IV infiltrates and an increase in catheter duration, these
changes were not statistically significant, and the IV infiltrate decrease was not sustained as we
actually saw a higher rate in April than in any of the pre intervention months.
While the unit had low BSI and CLABSI rates during the pre and post intervention
periods, that is not true of the first six months of 2019. BSI and CLABSI prevention has been a
focus of the ICU for over 10 years and while we have made great progress in decreasing these
infections over the years, we continue to fall short of our goal of zero. Although the
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interventions were not able to show a reduction in BSI or CLABSI rates, the interventions put in
place has been shown to reduce these infection rates in other centers (Devries et al, 2016). It is
believed that if the interventions implemented were continued over a longer period of time, a
decrease in overall BSI rates will be seen.
Increased EPIV utilization was predicted to decrease the number of IV attempts patient’s
experience in addition to decreasing PIV infiltrates. However, EPIV insertions were very low.
During the post implementation period, only 3 successful EPIV insertions occurred and 1
additional attempt was made during the 5-month post intervention period. This is actually fewer
than the pre-intervention period when 5 insertions and 1 additional attempt occurred.
There are four key factors that could have impacted the low EPIV utilization. First, the
IV team had vacancies on their team during the project period resulting in shifts without a team
member to insert an EPIV. We have recently expanded our IV team and feel that with focused
energy around EPIV insertions, IV infiltrate rates, as well as the number of PIVs during one
admission, could decrease from the current average of 5-6 per patient. Second, blood
administration is contraindicated in the size of EPIV catheters we currently utilize, making a PIV
a better option for some patients. There are several options of EPIV catheters for adult patients,
but pediatrics has limited catheter availability. There are currently attempts being made to create
EPIV catheters as small as a 24 gauge, which is very similar to that of a PIV catheter. However,
at the time of this project, the only available catheter required an introducer to access the vessel
and the threading of the small catheter through the introducer, which requires specialized
training, thus limiting those who could insert EPIVs. Third, new isolation precautions due to the
COVID-19 pandemic, with limited caregivers permitted in patient rooms, is thought to impact
low insertion rates. EPIVs were not essential if PIVs could be obtained by the bedside nurse.
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Therefore, the IV team was discouraged to enter patient rooms unless IV access could not be
obtained. Finally, the vascular access algorithm was not routinely used resulting in either no
consult for an EPIV or a late consult where the patient had already had multiple IV attempts and
had no sites remaining for insertion. Continued education regarding the vascular access
algorithm and feedback to the bedside RNs when a consult for an EPIV was missed should result
in increased utilization of the algorithm as well as increased insertion of EPIVs.

Limitations
There were many things that may have impacted the results of this project. However,
two factors played a key role. First, the PICU population changed over the course of the project.
In 2019, the PICU housed all pediatric ICU patients while in 2020, the cardiac patient population
was moved to a separate unit. The cardiac intensive care unit (CICU) population is primarily
post-operative cardiac patients who have a central line placed during their surgery. General
PICU patients predominantly have PIVs utilized for the majority of medications. Central access
is needed only for patients requiring vasoactive medications, long term antibiotics, or other
vesicant drugs. In addition, many of the PIVs in cardiac patients are inserted in the operating
room by anesthesia staff who are able to obtain larger IV catheters. Both factors may have
resulted in lower infiltrate rates for cardiac patients in 2019 thus preventing a statistically
significant decrease in 2020 when only looking at the PICU population.
Second, the census of the PICU was dramatically affected in 2020 because of COVID-19.
During March and April of 2020, the PICU had an average daily census (ADC) of 14 and 9
respectively compared to 23 and 23 in 2019. This decrease was attributed to the cancellation of
elective surgeries, the implementation of social isolation in our community, and the closure of
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schools and many other public places. Along with the decrease in census, we had many patients
who were admitted with new isolation precautions related to the pandemic, affecting the nursing
workflow and causing delays in every hour assessments of PIVs.
Conclusions
We are continuing to work on PIV infiltrates as a hospital and are working toward a
hospital wide bundle to roll out in 2020. Based upon the results of the PICU K card audits and
outcomes, the focus of the house-wide bundle will include accurate hourly TLC assessments and
expanding the use of EPIVs. The plan is for all nurses to receive mandatory education on proper
TLC assessments as well as signs and symptoms of IV infiltrates with a goal of expanding the
work over the next year.
While a statistically significant improvement was not seen in the key outcomes, the
project drew attention to the number of IV insertions and the number of IV attempts patients
endure during a hospital stay. Newer technology such as the IV Watch system (Doellman &
Rineair, 2019), has emerged in the last few years aiding in earlier detection of PIV infiltrates.
This technology utilizes infrared sensors to detect an infiltrate before it has external visible signs.
While the results have been favorable, the costs of the equipment would be substantial to have it
available for every patient with a PIV. However, future work on PIV infiltrate prevention could
incorporate this technology and limit the human error factor of inaccurate assessments.
Future research should focus on both EPIV usage in pediatrics as well as PIVIE bundle
implementation. The evidence is clear that some form of a PIVIE bundle is effective in
preventing the number and severity of IV infiltrates. However, it is not clear which components
are the key elements to impact these outcomes. As new EPIV catheters become available in
pediatric sizes, studying their usage to reduce IV infiltrates and severity would be beneficial. As
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more work continues within collaboratives such as Solutions for Patient Safety
(https://www.solutionsforpatientsafety.org/), I believe the best bundle components can be
identified.
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